Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Iconic Labs plc (ICON) Ord GBP0.0025

Sell:0.012p Buy:0.0125p 0 Change: 0.0009p (7.76%)
Market closed Prices as at close on 19 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.012p
Buy:0.0125p
Change: 0.0009p (7.76%)
Market closed Prices as at close on 19 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.012p
Buy:0.0125p
Change: 0.0009p (7.76%)
Market closed Prices as at close on 19 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Iconic Labs Plc, formerly WideCells Group PLC, is a United Kingdom-based company engaged in a media and technology business to deliver consultancy, products, marketing and distribution. The Company provides online marketing, content and technology driven products. The Company uses data insights to exploit trends and develop technologies. The Company provides content platform, which includes a suite of digital brands and technology products.

Contact details

Address:
Waverley House, 9 Noel Street
LONDON
W1F 8GO
United Kingdom
Telephone:
+44 (0161) 9207953
Website:
https://www.iconiclabs.co.uk/

Important dates

Future events
There are no future events available.
Past events
AGM 31 December 2020 31/12/20
Final results 10 December 2020 10/12/20
Annual report 10 December 2020 10/12/20
Trading Announcement 10 December 2020 10/12/20
Trading Announcement 18 September 2020 18/09/20

General stock information

EPIC:
ICON
ISIN:
GB00BD060S65
Market cap:
£4.68 million
Shares in issue:
37.41 billion
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • John Quinlan
    Interim Chairman of the Board
  • Brad Taylor
    Chief Executive Officer, Executive Director
  • Peter Hollands
    Group Chief Scientific Officer
  • Sam Asante
    Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.